Targeted News Service logo

-- Preview Email Newsletter
*Public Policy Tipoffs Involving Maryland Newsletter for 2024-11-17 ( 1 items )  
Johns Hopkins Medicine: Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers (10)
BALTIMORE, Maryland, Nov. 16 (TNSres) -- Johns Hopkins Medicine issued the following news release: A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a study by researchers from the Johns Hopkins Kimmel Cancer Center and Oregon Health & Science University. The immune microenvironment around a pancreatic tumor has suppressed immune activity, allowing the tumor to evade attacks by the immune s more PR